Wolverine Trading, LLC Cue Biopharma, Inc. Transaction History

Wolverine Trading, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$2.23 - $4.69 $24,815 - $52,190	11,128 New	11,128 $25,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $25,099 - $59,673	-10,080 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.41 - $12.28 $44,452 - $123,782	10,080 New	10,080 $47,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.